Mechanisms of skin fibrosis and model mouse

Skin Research

Volumn 5, Issue SUPPL. 6, 2006, Pages 7-15

  Chujo, Sonoko ^a   Igawa, Yuka ^a   Shirasaki, Fumiaki ^a   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Basic fibroblast growth factor; Connective tissue growth factor; CTGF; Skin fibrosis, model mouse, b FGF; TGF ; Transforming growth factor beta

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; SKIN FIBROSIS; SUBCUTANEOUS TISSUE;

EID: 33646815353     PISSN: 13471813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. McCormick LL, Zhang Y, Tootell E, Gillian AC: Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999; 163: 5693-5699
2. Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC: Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002; 168: 3088-3098
3. Bou-Gharios G, Garrett LA, Rossert J et al: A potent far-upstream enhancer in the mouse pro alpha 2(1) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol 1996; 134: 1333-1344
4. Lopez-De Leon A, Rojkind M: A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embeddedn sections. J Histochem Cytochem 1985; 33: 737-743
5. LeRoy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM: Astrategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer? Arthritis Rheum 1989; 32: 817-25
6. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T: Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J. Clin. Invest 1990; 86: 917-922
7. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C: Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis. Rheum 1994; 37: 278-288
8. Igarashi A, Okochi H, Bradham DM, Grotendorst GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993; 4: 637-45
9. Takehara K: Growth regulation of skin fibroblasts. J Dermatol 2000; Sci 24 Suppl 1: S70-7
10. Igarashi A, Nashiro K, Kikuchi K. et al: Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol 1995; 105: 280-284
11. Sato S, Nagaoka T, Hasegawa M. et al: Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J. Rheumatol 2000; 27: 149-154
12. Shinozaki M, Kawara S, Hayashi N, Kakinuma T, Igarashi A, Takehara K: Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta-simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun 1997; 240: 292-7
13. Takehara K: Pathogenesis of systemic sclerosis. J Rheumatol 2003; 30: 755-759
14. Majors A, Ehrhart LA: Basic fibroblast growth factor in the extracellular matrix suppresses collagen synthesis and type III procollagen mRNA levels in arterial smooth muscle cell cultures.
15. Frank S, Michael Z, Bernhard H et al. Kidney Int. 2000; 57: 1521-1538
16. Kadono T, Kikuchi K, Kubo M, Fujimoto M, Tamaki K: J Am Acad Dermatol 1996; 35: 392-397
17. Denton CP, Shiwen X, Black CM, Pearson JD: J Invest Dermatol 1997; 108: 269-274
18. Yu C, Wang F, Jin C et al: Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol 2003; 163: 1653-1662